NCT01016795 Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma Status TERMINATED Phase PHASE2
NCT01015625 Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer Status COMPLETED Phase NA
NCT01013181 Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults Status COMPLETED Phase N/A
NCT01009879 Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants Status WITHDRAWN Phase PHASE4
NCT01002703 Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma Status UNKNOWN Phase PHASE1/PHASE2
NCT01001377 ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT01001208 The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis Status COMPLETED Phase PHASE3
NCT01000961 Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis Status COMPLETED Phase PHASE3
NCT00999167 A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy Status COMPLETED Phase PHASE2
NCT00997529 Mini Allo Stem Cell Transplantation for the Treatment of Solid Tumors Status COMPLETED Phase NA
NCT00997022 Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients Status COMPLETED Phase PHASE1
NCT00992459 Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders Status COMPLETED Phase PHASE3
NCT00986895 A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group Status COMPLETED Phase PHASE1
NCT00984815 Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment Status COMPLETED Phase PHASE3
NCT00984282 Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer Status COMPLETED Phase PHASE3
NCT00984217 Trial of Radiotherapy and Panitumumab in Salivary Gland Malignancies Status WITHDRAWN Phase PHASE2
NCT00980174 Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis Status COMPLETED Phase PHASE3